1. Home
  2. GFAI vs RVPH Comparison

GFAI vs RVPH Comparison

Compare GFAI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • RVPH
  • Stock Information
  • Founded
  • GFAI 2018
  • RVPH 2006
  • Country
  • GFAI Singapore
  • RVPH United States
  • Employees
  • GFAI N/A
  • RVPH N/A
  • Industry
  • GFAI Diversified Commercial Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • GFAI Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • GFAI 23.3M
  • RVPH 26.6M
  • IPO Year
  • GFAI N/A
  • RVPH N/A
  • Fundamental
  • Price
  • GFAI $1.11
  • RVPH $0.44
  • Analyst Decision
  • GFAI Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • GFAI 1
  • RVPH 5
  • Target Price
  • GFAI $4.50
  • RVPH $9.00
  • AVG Volume (30 Days)
  • GFAI 721.9K
  • RVPH 3.0M
  • Earning Date
  • GFAI 09-23-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • GFAI N/A
  • RVPH N/A
  • EPS Growth
  • GFAI N/A
  • RVPH N/A
  • EPS
  • GFAI N/A
  • RVPH N/A
  • Revenue
  • GFAI $36,347,373.00
  • RVPH N/A
  • Revenue This Year
  • GFAI $5.66
  • RVPH N/A
  • Revenue Next Year
  • GFAI $4.69
  • RVPH N/A
  • P/E Ratio
  • GFAI N/A
  • RVPH N/A
  • Revenue Growth
  • GFAI 0.18
  • RVPH N/A
  • 52 Week Low
  • GFAI $0.76
  • RVPH $0.30
  • 52 Week High
  • GFAI $3.88
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 39.64
  • RVPH 43.33
  • Support Level
  • GFAI $1.27
  • RVPH $0.44
  • Resistance Level
  • GFAI $1.48
  • RVPH $0.53
  • Average True Range (ATR)
  • GFAI 0.11
  • RVPH 0.04
  • MACD
  • GFAI -0.03
  • RVPH 0.02
  • Stochastic Oscillator
  • GFAI 7.14
  • RVPH 37.07

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: